Skip to main content
Larry Schlesinger, MD, Infectious Disease, San Antonio, TX

Larry S Schlesinger MD


Professor, President, CEO, Texas Biomedical Research Institute

Join to View Full Profile
  • Texas biomedical Research Institute8715 W Military DrSan Antonio, TX 78227

  • Phone+1 210-258-9419

Dr. Schlesinger is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Infectious Disease, 1986 - 1989
  • University of Michigan
    University of MichiganResidency, Internal Medicine, 1982 - 1986
  • Rutgers Robert Wood Johnson Medical School
    Rutgers Robert Wood Johnson Medical SchoolClass of 1982

Certifications & Licensure

  • OH State Medical License
    OH State Medical License Active through 2014

Publications & Presentations

PubMed

Press Mentions

  • My Oral Cancer Shows the Deep Connections Between Chronic and Infectious Disease
    My Oral Cancer Shows the Deep Connections Between Chronic and Infectious DiseaseDecember 16th, 2024
  • San Antonio’s South, West Sides to Get More Medical Facilities, New Public Health School
    San Antonio’s South, West Sides to Get More Medical Facilities, New Public Health SchoolJune 10th, 2022
  • COVID-19 Vaccine Mandate by Texas Biomed Will Protect Not Just Humans
    COVID-19 Vaccine Mandate by Texas Biomed Will Protect Not Just HumansAugust 19th, 2021
  • Join now to see all

Grant Support

  • Impact of HIV on the human alveolar environment drivingthe early events of Mycobacterium tuberculosis infectionTEXAS BIOMEDICAL RESEARCH INSTITUTE2024–2029
  • Interdisciplinary NexGen TB research Advancement Center (IN-TRAC)TEXAS BIOMEDICAL RESEARCH INSTITUTE2022–2027
  • The Southwest National Primate Research Center Supplement- Infrastructure improvements of ABSL2 holding areasTEXAS BIOMEDICAL RESEARCH INSTITUTE2024–2025
  • The Southwest National Primate Research Center Supplement- Infrastructure improvements of ABSL2 holding areasTEXAS BIOMEDICAL RESEARCH INSTITUTE2024–2025
  • The Southwest National Primate Research Center Supplement- Infrastructure improvements of ABSL2 holding areasTEXAS BIOMEDICAL RESEARCH INSTITUTE2024–2025
  • Macrophage nuclear receptors, metabolism and immune effectors during health and M. tuberculosis infectionTEXAS BIOMEDICAL RESEARCH INSTITUTE2019–2025
  • Host Bacterial Targets Mediating Immune Suppression In Pneumonic TularemiaNational Institute Of Allergy And Infectious Diseases2009–2012
  • Medical Scientist Training Program - Ohio State UniversityNational Institute Of General Medical Sciences2011
  • Interdisciplinary Study Of The Microbe-Host InterfaceNational Institute Of Allergy And Infectious Diseases2007–2011
  • Acquisition Of A MALDI-TOF/TOF MS For Glycomic And Lipidomic ResearchNational Center For Research Resources2010
  • Altered M. Tuberculosis Mannosylation And The MacrophageNational Institute Of Allergy And Infectious Diseases2006–2010
  • TB And Innate Immune Regulation Of Lung MacrophagesNational Institute Of Allergy And Infectious Diseases2005–2009
  • Lung Innate Immure Responses To F. Tularensis: A Central Role For The MacrophageNational Institute Of Allergy And Infectious Diseases2008
  • Mycobacterium Tuberculosis Lipoarabinomannan Metabolism Within Human MacrophagesNational Institute Of Allergy And Infectious Diseases2007–2008
  • Altered Mycobacterium Tuberculosis Mannosylation And The MacrophageNational Institute Of Allergy And Infectious Diseases2007
  • TB And Innate Immune Regulation Of Lung MacrophagesNational Institute Of Allergy And Infectious Diseases2004
  • Macrophage Complement Receptors In TuberculosisNational Institute Of Allergy And Infectious Diseases2002
  • Altered M. Tuberculosis Mannosylation And The MacrophageNational Institute Of Allergy And Infectious Diseases2002
  • Surfactant Proteins In Pathogenesis Of TuberculosisNational Center For Research Resources2000–2002
  • Macrophage Complement Receptors In TuberculosisNational Institute Of Allergy And Infectious Diseases1998–2002
  • Gallium Therapy For Mycobacterial InfectionsNational Institute Of Allergy And Infectious Diseases1998–1999
  • Surfactant Proteins In The Pathogenesis Of TuberculosisNational Center For Research Resources1997
  • Surfactant Proteins In The Pathogenesis Of TuberculosisNational Heart, Lung, And Blood Institute1993–1997
  • Macrophage Complement Receptors In TuberculosisNational Institute Of Allergy And Infectious Diseases1992–1996
  • Human Monocyte Interactions W/Mycobacterium LepraeNational Institute Of Allergy And Infectious Diseases1988–1991

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: